Identification | Back Directory | [Name]
BETA-CCB | [CAS]
84454-35-3 | [Synonyms]
b-CCB β-CCB C13805 BETA-CCB β CCB,βCCB Butylβ-carboline-3-carboxylate Butylb-carboline-3-carboxylate N-Butyl-β-carboline-3-carboxylate BUTYL BETA-CARBOLINE-3-CARBOXYLATE N-BUTYL-B-CARBOLINE-3-CARBOXYLATE (B-CCB ) BETA-CARBOLINE-3-CARBOXYLIC ACID BUTYL ESTER 9H-Pyrido[3,4-b]indole-3-carboxylic acid, butyl ester | [Molecular Formula]
C16H16N2O2 | [MDL Number]
MFCD00078568 | [MOL File]
84454-35-3.mol | [Molecular Weight]
268.31 |
Hazard Information | Back Directory | [Uses]
beta-CCB (cas# 84454-35-3) has proconvulsant and anxiogenic effects, and it is an endogenous benzodiazepine binding inhibitor from brain. | [Definition]
ChEBI: N-Butyl-beta-carboline-3-carboxylate is a member of beta-carbolines. | [Biological Activity]
An endogenous proconvulsant and anxiogenic benzodiazepine receptor ligand. |
|
Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Website: |
https://www.bocsci.com |
Company Name: |
MOLEKULA Ltd.
|
Tel: |
+44 (0) 1747 831066 |
Website: |
www.molekula.co.uk |
|